Geode Capital Management’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$181K Sell
37,026
-4,354
-11% -$27.2K ﹤0.01% 3949
2026
Q1
$325K Buy
41,380
+9,983
+32% +$103K ﹤0.01% 3743
2025
Q4
$371K Buy
31,397
+4,114
+15% +$35.5K ﹤0.01% 3705
2025
Q3
$219K Buy
27,283
+354
+1% +$2.46K ﹤0.01% 3893
2025
Q2
$216K Sell
26,929
-376
-1% -$2.75K ﹤0.01% 3846
2025
Q1
$193K Buy
27,305
+727
+3% +$7.86K ﹤0.01% 3863
2024
Q4
$302K Buy
26,578
+1,102
+4% +$14.4K ﹤0.01% 3760
2024
Q3
$357K Buy
25,476
+3,920
+18% +$62.4K ﹤0.01% 3709
2024
Q2
$342K Buy
21,556
+2,342
+12% +$57.3K ﹤0.01% 3714
2024
Q1
$519K Buy
19,214
+2,604
+16% +$62.7K ﹤0.01% 3598
2023
Q4
$336K Hold
16,610
﹤0.01% 3752
2023
Q3
$219K Buy
16,610
+14
+0.1% +$230 ﹤0.01% 3946
2023
Q2
$312K Hold
16,596
﹤0.01% 3837
2023
Q1
$318K Hold
16,596
﹤0.01% 3838
2022
Q4
$458K Sell
16,596
-1,031
-6% -$26K ﹤0.01% 3695
2022
Q3
$440K Buy
17,627
+41
+0.2% +$1.62K ﹤0.01% 3781
2022
Q2
$830K Sell
17,586
-14,680
-45% -$686K ﹤0.01% 3507
2022
Q1
$2M Sell
32,266
-1,350
-4% -$111K ﹤0.01% 3257
2021
Q4
$4.27M Buy
33,616
+9,950
+42% +$1.62M ﹤0.01% 2983
2021
Q3
$4.71M Sell
23,666
-2,789
-11% -$665K ﹤0.01% 2938
2021
Q2
$7M Buy
26,455
+4,230
+19% +$1.31M ﹤0.01% 2702
2021
Q1
$7.77M Buy
22,225
+6,169
+38% +$2.63M ﹤0.01% 2529
2020
Q4
$8.21M Buy
16,056
+5,369
+50% +$2.15M ﹤0.01% 2296
2020
Q3
$2.8M Buy
10,687
+114
+1% +$39.2K ﹤0.01% 2700
2020
Q2
$5.78M Buy
+10,573
New +$4.75M ﹤0.01% 2251

Other funds holding PASG

Geode Capital Management's PASG Position: Q2 2026 in Review

Geode Capital Management reduced its Passage Bio (PASG) stake by 11% in Q2 2026, selling an estimated $27.2K and leaving 37,026 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #3949.

Geode Capital Management first reported a position in PASG in Q2 2020 and has held it in 25 quarters since. The position peaked at $8.21M in Q4 2020. 28 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • Geode Capital Management held 37,026 shares of Passage Bio worth $181K as of Q2 2026.
  • Geode Capital Management sold 4,354 Passage Bio shares in Q2 2026, an estimated $27.2K.
  • Passage Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3949 holding.
  • Geode Capital Management first reported a position in Passage Bio in Q2 2020 and has held it in 25 quarters since.
  • Geode Capital Management's Passage Bio position peaked at $8.21M in Q4 2020.
  • 28 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.